European Association for Automated Dose Dispensing (EAADD)

A European non-profit association of professionals from the world of pharmaceuticals specialising in automated dose dispensing (ADD)

Our
EAADD Association

Has a mission to harmonise and coordinate expansion and best practices in the use of blister packaging and automated dose dispensing (ADD), standardising criteria at European level to benefit people’s well-being and health

Maximum drug adherence
Guarantee of safety and zero errors
Trust, care and security
Technology at the service of health and people
Sustainability of the health system

ADD and ADHERENCE TO TREATMENT

The WHO defines adherence to long-term therapy as “the extent to which a person’s behavior—taking medication, following a diet, and/or executing lifestyle changes—corresponds with agreed recommendations from a health care provider.” Often, the terms adherence and compliance are used interchangeably. However, their connotations are somewhat different: adherence presumes the patient’s agreement with the recommendations, whereas compliance implies patient passivity. Both terms are problematic in describing medication-taking behavior because they exaggerate the physician’s control over the process of taking medications. The complex issues surrounding the taking of medication for chronic disease cannot easily be distilled into one word. Recognition of this complexity will help avoid assigning blame exclusively to the patient and assist in identifying effective solutions.
European Guidelines

The European Directorate for the Quality of Medicines and HealthCare (EDQM) of the Council of Europe published Guidelines on “Best Practice for the Automated Dose Dispensing (ADD) Process and Care and Safety of Patients”, a document to which Spain and the other EU countries are signatories.

Main Goals

Articles and press coverage

Any questions?